Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-25-019371
Filing Date
2025-10-24
Accepted
2025-10-24 17:29:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 form424b5.htm 424B5 471500
2 GRAPHIC form424b5_001.jpg GRAPHIC 6184
  Complete submission text file 0001493152-25-019371.txt   481472
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-280244 | Film No.: 251417034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)